Seneca Partners

Seneca Partners Limited is a private equity firm based in Newton-Le-Willows, United Kingdom, that specializes in special situations investments. Established in 2010, the firm primarily targets small and medium-sized enterprises (SMEs) within the UK, making investments ranging from £0.5 million to £3 million. Seneca Partners has garnered recognition for its expertise in SME investment and advisory services, winning the "Alternative Finance Provider" award at the North West Business Insider Awards in both 2016 and 2017. The management team brings extensive experience from various sectors, including private equity and corporate finance. In addition to its primary operations, Seneca Partners is a founding member of a network of companies under the Seneca brand, which encompasses several entities, including a fund manager and a property financing provider. This network operates from multiple offices in the North of England and employs over 60 people.

17 past transactions

HubBox

Venture Round in 2023
HubBox is the first universal Click & Collect solution for online retailers. Their market-leading software means that any retailer can strengthen their delivery proposition by offering local Click & Collect and in-store pick up at checkout. Their software powers Click & Collect for hundreds of retailers, including brands such as Boohoo, Whistles, hmv, Warehouse and TM Lewin.

SolasCure

Series A in 2021
SolasCure Limited is a company based in Wales, United Kingdom, that specializes in developing innovative wound care products for patients with chronic wounds. Founded in 2017, the company has created Aurase, a hydrogel designed for wound debridement, a therapeutic procedure that removes dead, damaged, or infected tissue to enhance the healing process. SolasCure is committed to supporting healthcare professionals by providing effective solutions that improve patient health and wellbeing.

Gelmetix

Series C in 2021
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.

Bright

Series B in 2020
Bright Network operates a social recruitment site for graduates and young professionals. The company was formerly known as Bright London (UK) Limited. It was incorporated in 2007 and is based in London, United Kingdom.

Gelmetix

Series C in 2020
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.

Vizibl

Series A in 2019
We build software that enables Enterprises to forge deeper and more valuable relationships with their Buyers and Suppliers. Our products and platforms increase innovation, collaboration, alignment and agility. Decrease risks, costs, duplication and time to action. And they improve processes, productivity, accountability and connections. We call it ‘Enterprise Level Innovation’.

Fabacus

Seed Round in 2019
Fabacus Holdings Limited, established in 2013 and based in London, United Kingdom, has developed Xelacore, a platform that enhances the licensing process by connecting licensors, licensees, agents, and retailers. The company aims to address the challenges of the fragmented licensing and supply chain landscape, offering greater visibility and control to all participants. By focusing on transparency within the supply chain, Fabacus seeks to provide a competitive edge in the licensing industry. The team comprises experienced leaders from retail and licensing, alongside experts in large-scale cloud-based systems. Collaborations with prominent licensors, agents, global standards organizations, and logistics operators have been instrumental in creating a solution that aims to revolutionize the licensing landscape for all stakeholders involved.

The Hook Group

Private Equity Round in 2019
The Hook Group has rapidly grown into one of the worlds leading media groups dominating the shift to social. Made up of two divisions: 1. Marketing - The Hook Labs: Voted the UK's #1 Social Marketing Agency, The Hook Labs scales brands and makes them famous on social, through a combination of social first content, influencer marketing and its distribution network of over 1bn people. It is a market leader in scaling social commerce sales. 2. Media - The Hook: Rapidly grown into one of the largest youth entertainment channels on social, with an asset based of 12.7m followers. Focussed on pop culture, it creates and curates content that makes its fan laugh or be inspired - from funny interviews with Hollywood actors to inspiring mini-docs about great athletes.

Gelmetix

Series B in 2018
Gelmetix Limited develops injectable gel-based therapeutic biomaterial medical devices for bone disorders and early-stage degenerative disc disease. The company offers microgel therapy for chronic low back pain, small joints osteoarthritis, and knee osteoarthritis. The company was formerly known as Gelexir Healthcare Ltd and changed its name to Gelmetix Limited in July 2018. Gelmetix Limited was founded in 2012 and is based in Nether Alderley, United Kingdom with additional offices in London and Manchester, United Kingdom; and Paris, France.
SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. The company focuses on the development of SkinBiotix technology for use in cosmetic, infection control, and eczema applications. It has an agreement with Croda International Plc for the design and manufacture of a new active cosmetic skincare ingredient based on its SkinBiotix skin microbiome technology. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Macclesfield, the United Kingdom.

Redx Pharma

Post in 2017
Redx Pharma is a UK-based drug discovery and development company founded in 2010, focusing on creating innovative small molecule drugs aimed at treating cancer, fibrosis, and other unmet medical needs. The company is advancing several key drug candidates, including RXC004, a porcupine inhibitor in Phase I clinical trials for various cancers, and a ROCK inhibitor targeting inflammatory diseases related to fibrosis. Other notable developments include a Rho-associated protein kinase 2 inhibitor for diabetic nephropathy and idiopathic pulmonary fibrosis, along with a Pan-RAF inhibitor and SHP2 for cancer treatment. Additionally, Redx Pharma collaborates with Jazz Pharmaceuticals to explore drug candidates targeting the Ras/Raf/MAP kinase pathway. The company operates through three subsidiaries: Redx Oncology, Redx Anti-Infectives, and Redx Immunology, and has established partnerships with major pharmaceutical firms and the NHS to enhance its research and development efforts.

Apex Molecular

Venture Round in 2016
Apex Molecular Ltd provides specialist chemistry services to pharmaceutical, biotechnology (life sciences), and applied chemistry sectors. The company offers laboratory-scale chemistry development services, including high potency synthesis, custom/contract synthesis, and development and scale-up. Its customers include drug discovery, biotechnology, and agritech companies. The company was formerly known as YProTech Ltd. and changed its name to Apex Molecular Ltd in 2019. Apex Molecular Ltd was incorporated in 2008 and is based in Alderley Edge, United Kingdom.

Sorted Group

Venture Round in 2016
Sorted Group is a global software as a service (SaaS) company based in Manchester, United Kingdom, specializing in solutions that enhance the delivery and post-purchase experience for online retailers. Founded in 2010, the company offers a range of products designed to streamline operations, including SortedHERO, which provides real-time delivery options at checkout; SortedPRO, which facilitates scalable delivery management by connecting to various carrier services; and SortedREACT, a platform for tracking shipments. By focusing on data-driven software, Sorted Group aims to simplify carrier management and delivery tracking for its customers worldwide.

INC. Travel Group

Venture Round in 2016
Inc. Travel Group exist to positively shape your travel experience by using our insights.

W.S. Rothband & Co

Acquisition in 2015
W.S. Rothband & Co Ltd. is a manufacturer based in Rossendale, United Kingdom, specializing in lead aprons and other radiation protection products for radiology environments across Europe and the Middle East. Founded in 1860, the company offers a diverse range of products, including lead apron repairs, storage solutions, protective screens and shields, structural shielding, and lead curtains. Its extensive product categories encompass items related to bone densitometry, mammography, MRI, ultrasound, and quality assurance, as well as darkroom and processing solutions. W.S. Rothband & Co. is committed to providing essential safety equipment and accessories for medical professionals operating in environments where radiation exposure is a concern.

23.5 Degrees

Venture Round in 2015
23.5 Degrees Limited is a franchise operator of Starbucks coffee shops, established in 2012 and headquartered in Southampton, United Kingdom. It was recognized as Starbucks' first global franchisee, opening its inaugural store in February 2013. Currently, 23.5 Degrees manages 42 stores, with an additional 35 locations approved for development. The company operates within a designated territory that encompasses various regions in both the South and North of England, including counties such as Oxfordshire, Berkshire, and Lancashire. The stores offer a diverse menu featuring handmade coffees, milkshakes, cookies, and desserts, catering to a wide range of customer preferences. The business is led by Managing Director Mark Hepburn, who has extensive experience in the food service franchise sector, previously working with brands like Burger King and KFC. The growth of 23.5 Degrees is bolstered by support from private equity firm Connection Capital and RBS.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.